Streetbeat News

Stock Prices

GHM

NKLA

THR

Five industrials sector stocks are identified as overbought based on their RSI values, indicating potential short-term performance concerns. Nikola Corporation, Graham Corporation, BrightView Holdings, Thermon Group Holdings, and Air Lease Corporation have all seen significant price increases recently, pushing their RSI values above the typical overbought threshold of 70. This could signal a warning to momentum investors about the possibility of a downturn.

Portfolio Pulse from Avi Kapoor

April 01, 2024 | 12:10 pm

DOMA

MCAF

VSTE

Doma Holdings Inc. shares surged 34.1% in pre-market trading after announcing a merger with TRG to go private at $6.29 per share. Other stocks showed significant movement in pre-market trading, with Vast Renewables Limited leading the gainers with a 213.9% increase, and Mountain Crest Acquisition Corp. IV leading the losers with a 58.7% decrease. The movements were influenced by various factors including earnings reports, strategic partnerships, and public offerings.

Portfolio Pulse from Avi Kapoor

April 01, 2024 | 12:08 pm

CURV

EZGO

OXM

SLNA

In Monday's pre-market session, several consumer discretionary stocks showed notable movements. Selina Hospitality (SLNA) led the gainers with a 26.8% increase, while EZGO Technologies (EZGO) experienced the largest drop among the losers, decreasing by 16.1%. Other notable mentions include Torrid Holdings (CURV) with a 16.8% rise following their Q4 earnings release, and Oxford Industries (OXM) falling 10.97% also after their Q4 earnings announcement.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 12:08 pm

GRTX

NDRA

In Monday's pre-market session, several healthcare stocks showed significant movement. Galera Therapeutics (GRTX) led the gainers with a 62.8% increase, attributed to its Q4 earnings report. Other notable gainers include Sunshine Biopharma (SBFM), Qilian Intl Hldg Gr (QLI), Xilio Therapeutics (XLO), Innate Pharma (IPHA), and China Pharma Holdings (CPHI). On the losing side, ENDRA Life Sciences (NDRA) saw the largest drop of 29.3%, also following its Q4 earnings. Other decliners were SINTX Techs (SINT), Fractyl Health (GUTS), Vivos Therapeutics (VVOS), Avalo Therapeutics (AVTX), and Applied Therapeutics (APLT).

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 12:08 pm

MMM

VSTE

In Monday's pre-market session, Vast Renewables, Nuburu, American Rebel Holdings, Graham, Astra Space, and Shimmick saw gains, while Nuvve Holding, 3M, FREYR Battery, Energous, Quhuo, and Pineapple Energy experienced declines. Notable movements include Vast Renewables' 211.7% increase and 3M's 14.21% decrease.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 12:08 pm

CLSK

GDS

MIMO

SPEC

WRAP

XTKG

In Monday's pre-market session, several information technology stocks showed notable movements. Airspan Networks, Spectaire Holdings, and Wrap Technologies were among the top gainers, with Airspan leading at a 15% increase. On the downside, X3 Holdings, Cleanspark, and Movella Holdings experienced significant drops, with X3 Holdings leading the losses at 28.2%. Wrap Technologies and GDS Holdings also released their Q4 earnings recently, influencing their stock movements.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 12:07 pm

JAGX

Jaguar Health (NASDAQ:JAGX) reported Q4 sales of $2.30 million, missing the consensus estimate of $2.61 million by 11.88% and marking a 29.45% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:07 pm

SGRP

SPAR Group (NASDAQ:SGRP) reported a Q4 EPS of $0.11, up 37.5% from $0.08 YoY, with sales of $65.10M beating the $65.00M estimate, a 0.71% increase YoY.

Portfolio Pulse from dijoy@benzinga.com

April 01, 2024 | 12:05 pm

MULN

Mullen Automotive, Inc. (NASDAQ: MULN), an electric vehicle manufacturer, has filed for Foreign Trade Zone status in Tunica, Mississippi, aiming to improve cash flow by deferring taxes, fees, and import duties. The company anticipates a decision within 30 to 90 days and estimates a deferral of $10 million in capital outlays for FY 2024. FTZ status would also enhance global competitiveness and supply chain performance, with significant benefits for both domestic and international sales.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:04 pm

TLSI

TriSalus Life Sciences (NASDAQ:TLSI) reported Q4 2023 earnings with a GAAP EPS of $(1.56), missing the $(0.69) estimate by 126.09%. However, their sales of $5.721M exceeded the $5.453M estimate by 4.91%, marking a 77.34% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:02 pm